Kazia Therapeutics BAIIA

Quel est le BAIIA de Kazia Therapeutics?

Le BAIIA de Kazia Therapeutics Limited est -AUD$22.91

Quelle est la définition de BAIIA?

Le BAIIA est le bénéfice avant intérêts, impôts, dépréciations et amortissements d’une entreprise. Il s’agit d’une mesure comptable calculée à partir du bénéfice net avant de sustraire les intérêts, impôts et amortissements d’une entreprise, comme mesure de la rentabilité opérationnelle courante de l’entreprise.

Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.